Abstract
Since the publication of the landmark paper by Dr. Emanuel Rivers in The New England Journal of Medicine in 2001, the world of critical care massively adopted his protocol for the resuscitation of severe sepsis and/or septic shock—which was named “early goal-directed therapy” [1]. The concept of goal-directed therapy rapidly arose from sepsis and was applied to shock in general in the intensive care unit. Goal-directed therapy is a bundle of care that embraces the use of fluids, blood transfusion, and inotropes aiming to precise hemodynamic targets [2]. In case of hypotension or lactate raise, a fluid challenge of 30 ml/kg of crystalloid solution is administered to the patient. Fluid responsiveness is assessed in terms of low central venous pressure (CVP) and decreases in heart rate. In the following hours, hemodynamic targets include: a CVP of 8–12 mmHg, a superior vena cava oxygen saturation (ScvO2) >70% or a mixed venous oxygen saturation (SvO2) >65%, a mean arterial pressure (MAP) ≥65 mmHg, and a urine output ≥0.5 mL/kg/h. Strategies to achieve these target involve additional fluids, transfusion of packed red blood cells or inotrope infusion. In the original study, the application of this protocol reduced mortality by more of one third and halved that of patients with severe sepsis [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77. https://doi.org/10.1056/NEJMoa010307.
Gordon AC, Russell JA. Goal directed therapy: how long can we wait? Crit Care. 2005;9(6):647–8. https://doi.org/10.1186/cc3951.
Investigators PCESS, Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–93. https://doi.org/10.1056/NEJMoa1401602.
Investigators ARISE, ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–506. https://doi.org/10.1056/NEJMoa1404380.
Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–11. https://doi.org/10.1056/NEJMoa1500896.
Investigators PRISM, Rowan KM, Angus DC, et al. Early, goal-directed therapy for septic shock - a patient-level meta-analysis. N Engl J Med. 2017;376(23):2223–34. https://doi.org/10.1056/NEJMoa1701380.
Edriss H. What comes after the early goal directed therapy for sepsis era? J Thorac Dis. 2017;9(10):3514–7. https://doi.org/10.21037/jtd.2017.09.27.
Russell JA, Rush B, Boyd J. Pathophysiology of septic shock. Crit Care Clin. 2018;34(1):43–61. https://doi.org/10.1016/j.ccc.2017.08.005.
Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247–56. https://doi.org/10.1056/NEJMoa040232.
Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412–21. https://doi.org/10.1056/NEJMoa1305727.
Park CHL, de Almeida JP, de Oliveira GQ, et al. Lactated Ringer's versus 4% albumin on lactated Ringer's in early sepsis therapy in cancer patients: a pilot single-center randomized trial. Crit Care Med. 2019;47(10):e798–805. https://doi.org/10.1097/CCM.0000000000003900.
Xu JY, Chen QH, Xie JF, et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials. Crit Care. 2014;18(6):702. https://doi.org/10.1186/s13054-014-0702-y.
Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367(2):124–34. https://doi.org/10.1056/NEJMoa1204242.
Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125–39. https://doi.org/10.1056/NEJMoa070716.
Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370(17):1583–93. https://doi.org/10.1056/NEJMoa1312173.
Lamontagne F, Meade MO, Hébert PC, et al. Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med. 2016;42(4):542–50. https://doi.org/10.1007/s00134-016-4237-3.
Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009;37(9):2642–7. https://doi.org/10.1097/CCM.0b013e3181a590da.
Biais M, Nouette-Gaulain K, Cottenceau V, Revel P, Sztark F. Uncalibrated pulse contour-derived stroke volume variation predicts fluid responsiveness in mechanically ventilated patients undergoing liver transplantation. Br J Anaesth. 2008;101(6):761–8. https://doi.org/10.1093/bja/aen277.
Lanspa MJ, Grissom CK, Hirshberg EL, Jones JP, Brown SM. Applying dynamic parameters to predict hemodynamic response to volume expansion in spontaneously breathing patients with septic shock. Shock. 2013;39(2):155–60. https://doi.org/10.1097/SHK.0b013e31827f1c6a.
Maughan BC, Seigel TA, Napoli AM. Pleth variability index and fluid responsiveness of hemodynamically stable patients after cardiothoracic surgery. Am J Crit Care. 2015;24(2):172–5. https://doi.org/10.4037/ajcc2015864.
Orso D, Paoli I, Piani T, Cilenti FL, Cristiani L, Guglielmo N. Accuracy of ultrasonographic measurements of inferior vena cava to determine fluid responsiveness: a systematic review and meta-analysis. J Intensive Care Med. 2020;35(4):354–63. https://doi.org/10.1177/0885066617752308.
Cho RJ, Williams DR, Leatherman JW. Measurement of femoral vein diameter by ultrasound to estimate central venous pressure. Ann Am Thorac Soc. 2016;13(1):81–5. https://doi.org/10.1513/AnnalsATS.201506-337BC.
Beaubien-Souligny W, Benkreira A, Robillard P, et al. Alterations in portal vein flow and intrarenal venous flow are associated with acute kidney injury after cardiac surgery: a prospective observational cohort study. J Am Heart Assoc. 2018;7(19):e009961. https://doi.org/10.1161/JAHA.118.009961.
Richard C, Warszawski J, Anguel N, et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2003;290(20):2713–20. https://doi.org/10.1001/jama.290.20.2713.
Parker MM, Peruzzi W. Pulmonary artery catheters in sepsis/septic shock. New Horiz. 1997;5(3):228–32.
Hernández G, Ospina-Tascón GA, Damiani LP, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321(7):654–64. https://doi.org/10.1001/jama.2019.0071.
Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest. 2000;117(1):260–7. https://doi.org/10.1378/chest.117.1.260.
De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med. 2012;40(3):725–30. https://doi.org/10.1097/CCM.0b013e31823778ee.
Vasu TS, Cavallazzi R, Hirani A, Kaplan G, Leiby B, Marik PE. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. J Intensive Care Med. 2012;27(3):172–8. https://doi.org/10.1177/0885066610396312.
McIntyre WF, Um KJ, Alhazzani W, et al. Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA. 2018;319(18):1889–900. https://doi.org/10.1001/jama.2018.4528.
Nguyen HB, Lu S, Possagnoli I, Stokes P. Comparative effectiveness of second vasoactive agents in septic shock refractory to norepinephrine. J Intensive Care Med. 2017;32(7):451–9. https://doi.org/10.1177/0885066616647941.
Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371(15):1381–91. https://doi.org/10.1056/NEJMoa1406617.
Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group. N Engl J Med. 1999;340(6):409–17. https://doi.org/10.1056/NEJM199902113400601.
Retter A, Wyncoll D, Pearse R, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol. 2013;160(4):445–64. https://doi.org/10.1111/bjh.12143.
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564–75. https://doi.org/10.1056/NEJMoa062200.
Silversides JA, Major E, Ferguson AJ, et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2017;43(2):155–70. https://doi.org/10.1007/s00134-016-4573-3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nardelli, P., Senarighi, G., Votta, C.D. (2021). Goal-Directed Therapy. In: Landoni, G., Baiardo Redaelli, M., Sartini, C., Zangrillo, A., Bellomo, R. (eds) Reducing Mortality in Critically Ill Patients. Springer, Cham. https://doi.org/10.1007/978-3-030-71917-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-71917-3_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71916-6
Online ISBN: 978-3-030-71917-3
eBook Packages: MedicineMedicine (R0)